Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Clavubactin batches recalled over reduced efficacy
'This recall is because the efficacy of the product cannot be guaranteed after 12 months' - VMD.

Vets and wholesalers urged to examine their inventory immediately

The Veterinary Medicines Directorate (VMD) has issued a product defect recall alert for batches of the antibiotic Clavubactin, manufactured by Le Vet Pharma.

In a news release, the VMD writes: ‘We wish to make wholesalers and veterinary surgeons aware that Le Vet Pharma has issued a recall for batches of Clavubactin 50/12.5mg (Vm 19994/4028), Clavubactin 250/62.5mg (Vm 19994/4026), Clavubactin 500/125mg (Vm 19994/4027), all distributed by Animalcare and Dechra.

‘During routine stability testing the above-mentioned products do not fulfil the mandatory testing requirements at 24 months. This recall is because the efficacy of the product cannot be guaranteed after 12 months.’

The recall affects the following batches:

Product names Batch numbers Expiry
Clavubactin 50/12.5 mg 19D82 04-2021
  18D11 04-2020
  18G32 07-2020
Clavubactin 250/62.5 mg 19D83 04-2022
  17F46 06-2020
  17H35 08-2020
  18D13 04-2021
Clavubactin 500/125 mg 19D88 04-2022
  17C80 03-2020
  17F47 06-2020
  17H38 08-2020
  18D17 04-2021
  18D18 04-2021
  18G34 04-2022


Veterinary surgeons and wholesalers are urged to examine their inventory without delay and quarantine products subject to this recall.

For more information, please contact the relevant distributor:

Animalcare: Sameer Hashmi: shashmi@animalcare.co.uk
Dechra: Tracey Smith: tracey.smith@dechra.com

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.